KPWS
MRNS

Kestra Private Wealth Services’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Kestra Private Wealth Services’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200,000
Closed -$2.28M – 1033
2021
Q3 		$2.28M Buy
+200,000
New +$2.75M 0.13% 175
2021
Q1 		– Sell
-200,000
Closed -$2.47M – 854
2020
Q4 		$2.47M Buy
+200,000
New +$2.79M 0.18% 134

Other funds holding MRNS

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Kestra Private Wealth Services's MRNS Position: Q4 2021 in Review

Kestra Private Wealth Services sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2021, closing a stake of 200,000 shares — an estimated $2.28M sold.

Kestra Private Wealth Services first reported a position in MRNS in Q4 2020 and held it in 2 quarters. The position peaked at $2.47M in Q4 2020. 75 funds tracked by Wall St. Rank hold MRNS as of Q4 2021.

  • Kestra Private Wealth Services reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2021 after selling out during the quarter.
  • Kestra Private Wealth Services sold 200,000 Marinus Pharmaceuticals, Inc shares in Q4 2021, an estimated $2.28M.
  • Kestra Private Wealth Services first reported a position in Marinus Pharmaceuticals, Inc in Q4 2020 and held it in 2 quarters.
  • Kestra Private Wealth Services's Marinus Pharmaceuticals, Inc position peaked at $2.47M in Q4 2020.
  • 75 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2021.

Based on Kestra Private Wealth Services's 13F filing for Q4 2021, filed 21 Jan 2022.